TCM
SIOX

Tang Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Tang Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,000,000
Closed -$870K – 123
2022
Q4 		$870K Buy
+2,000,000
New +$649K 0.13% 70

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Tang Capital Management's SIOX Position: Q1 2023 in Review

Tang Capital Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 2,000,000 shares — an estimated $870K sold.

Tang Capital Management first reported a position in SIOX in Q4 2022 and held it in 1 quarter. The position peaked at $870K in Q4 2022. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Tang Capital Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Tang Capital Management sold 2,000,000 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $870K.
  • Tang Capital Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Tang Capital Management's Sio Gene Therapies Inc. Common Stock position peaked at $870K in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Tang Capital Management's 13F filing for Q1 2023, filed 15 May 2023.